Verlag des Forschungszentrums Jülich
JUEL-3499 A new pathway for the no carrier added (n.c.a.) 18F-labelling of biogenic
arylalkylamines such as [18F]fluoronorephedrine and [18F]fluorometaraminol
(FMR) via nucleophilic aromatic substitution was developed. To overcome the problem of low
specific activity, not to avoid with previous electrophilic fluorination, 18F-labelled
arylalkylamines were synthesized by direct nucleophilic exchange with n.c.a. [18F]fluoride
starting with a keto-activated aromatic system and consecutive chiral reduction of the
keto-function. With regard to a stereoselective reduction of the carbonyl group, several N-protected
-aminopropiophenones were prepared as model compounds in order to examine the influence of
the protecting group on the radiochemical yield of a 18F-for-X substitution (X=
F, Cl, NO2, +N(CH3)3). Good radiochemical yields could be achieved using the N-dibenzyl- or acetyl-protected
compounds. The para-position of the leaving group provided higher radiochemical yields
than the ortho-position in the case of the 18F-for-19F substitution.
It has been shown that the less basic oxalate/cryptate system does not increase the
radiochemical yields. 18F-Fluorination of the nitro compound failed because the precursor was not
stable under labelling conditions. The best results of n.c.a. 18F-fluorination
were obtained using the trimethylammonium leaving group (X = +N(CH3)3)
in para-position (RCY about 50 %), however, a selective quaternisation of the
dimethylaniline group was only possible when using the N,N-dibenzylated derivative. The n.c.a. labelling of 4-[18F]fluoronorephedrine and 4-[18F]fluorometaraminol
was finally performed via 18F-for-N(CH3)3 substitution on
4-(2-N,N- dibenzylaminopropionyl)phenyl-1-N,N,N-trimethyl- ammonium triflate and
4-(2-N,N-dibenzylaminopropionyl)-2-benzyloxyphenyl-1-N,N,N-trimethyl- ammonium triflate,
respectively. The precursor of 4-[18F]fluorometaraminol has been synthesized in
an eleven step reaction sequence and characterized with IR and 1H-NMR. The formation of the threo-isomer of n.c.a. 4-[18F]fluoronorephedrine was
achieved by reduction of n.c.a. 2-N,N-dibenzylamino-1-(4-[18F]fluorophenyl)propan-1-on
using sodium borohydride in methanol as reducing agent. The radiochemical yield was about
20% after hydrogenolytical debenzylation using ammonium formate and palladium on charcoal.
The formation of the erythro-isomer of 4-[18F]fluoronorephedrine and 4- [18F]fluorometaraminol
was accomplished with BH3 THF in the presence of 2-N,N-dibenzylamino-1-(4- [18F]fluoro-
phenyl)propan-1-on and 2-N,N-dibenzylamino-1-(4-[18F]fluoro-3-benzyloxyphenyl)propan-1-on
respectively. The ratio of erythro- to threo-isomer was 4:1. The radiochemical yield of
erythro-4- [18F]fluoronorephedrine and erythro-4-[18F]fluorometaraminol
after deprotection using ammonium formate and palladium on charcoal was 15-20 ;#37; with a
specific activity of about 74 GBq/[my]mol (2 Ci/[my]mol). The new synthetic pathway makes it possible to synthesize these labelled
sympathomimetics no carrier added and to investigate the presynaptic adrenergic nervous
system of the heart using positron emission tomography.
Ermert, Johannes
Zur trägerarmen Markierung von Arylalkylaminen mit n.c.a. (18F)Fluorid am Beispiel von Norephedrin und Metaraminol
136 S., 1998
Neuerscheinungen
Schriften des Forschungszentrums Jülich
Ihre Ansprechperson
Heike Lexis
+49 2461 61-5367
zb-publikation@fz-juelich.de